Kite, a Gilead Company, Twitter Guidelines

Kite, a Gilead Company, maintains a @KitePharma Twitter account as a way to share Kite’s corporate news and advances in cell therapy. Our goal is to provide useful and interesting content about our company as well as educational information about cell therapy.

To ensure our communications are consistent with our mission and with applicable ethical, legal and regulatory standards, we have put in place the following basic guidelines and disclaimers to help you understand how we will use Twitter.

Guidelines:

  • Should you reply to or @ mention @KitePharma, please ensure your Tweets do not contain foul language or topics that do not relate directly to Kite or the communities it serves.
  • Kite does not view Twitter as a forum for product inquiries. For product information, please refer to the information on our corporate website at kitepharma.com or call (844) 454-KITE.
  • If your inquiry is of an urgent nature, please call (844) 454-KITE to speak with the appropriate Kite representative. Disclaimers:
  • Kite can’t engage in sensitive topics, or discussion(s) about our product candidates, clinical trials, financials or any legal or regulatory matters.
  • Kite is not providing and cannot provide medical advice. Any questions regarding your condition, treatment or medical side effects should be directed to your physician or other healthcare professional immediately.
  • Twitter accounts that @KitePharma follows or is followed by are not an indication of Kite’s endorsement of these accounts or the content they produce.
  • Kite may tweet links to other websites as part of its Tweets. However, Kite claims no responsibility for the accuracy or content of such other sites and shall not be liable for any damages or injury arising from that content. Any links to other sites are provided as merely a convenience to the users of this platform.
  • Any content, views, opinions, mentions and/or replies uploaded or expressed by any person other than Kite are solely the views, opinions and responsibility of the person uploading or expressing them and do not necessarily reflect the opinions of Kite.
  • Kite is not affiliated with Twitter.com or other Twitter sites.
  • Kite is not responsible for the security, privacy or other policies or practices on Twitter or on any of the third party websites that Kite may link to or reference through Twitter. You should carefully review the security, privacy and other policies and practices of Twitter and linked or referenced third-party websites.
  • Kite reserves all rights relating to the Kite Twitter account and may in its sole discretion add, remove or modify any content or material posted on the account, discontinue the account, accept or reject those who may wish to follow the account and respond to any questions or comments addressed to the account.
  • The Kite logo and images are trademarks of Kite and Kite owns all rights therein.
  • Any information expressed by Kite is subject to the risk factors and information no forward-looking statements contained in its filings with the Securities and Exchange Commission and available here: http://investors.gilead.com/phoenix.zhtml?c=69964&p=irol-sec.

Thank you for reading and for following @KitePharma on Twitter.

 

Kite, a Gilead Company, LinkedIn Guidelines

Kite, a Gilead Company, maintains a corporate page on LinkedIn as a way to share corporate news, advances in cell therapy and career opportunities. To ensure our communications are consistent with our mission and with applicable ethical, legal and regulatory standards, we have put in place the following basic guidelines and disclaimers to help you understand how we will use LinkedIn.

GUIDELINES:

  • Should you comment on our LinkedIn page please ensure your comments do not contain foul language, defamatory remarks about Kite employees or its associated workers or topics that do not relate directly to our posts. Please note; Kite reserves to the right to remove any comments with foul language or defamatory remarks from its corporate page and where suitable will connect with the comment author privately. Unless warranted Kite conducts a no reply policy.
  • Kite does not view its LinkedIn page as a forum for product inquiries. For product information, please refer to the information on our corporate website at kitepharma.com or call (844) 454-KITE.
  • Kite does not view its LinkedIn page as a forum for feedback on Kite products or reporting adverse effects. Where such comments are made, your comment may be deleted and this information will be passed on to our Drug Safety and Public Health team. They may be in contact with you directly for additional information if you provide contact details.

DISCLAIMERS:

  • Content shared on Kite’s LinkedIn page is provided for informational purposes only.
  • Any content, views, opinions, mentions and/or replies uploaded or expressed by any person other than Kite Sciences are solely the views, opinions and responsibility of the person uploading or expressing them and do not necessarily reflect the opinions of Kite. Kite is not responsible for content that third parties transmit via Kite’s LinkedIn page.
  • Kite may provide links or references to other websites as part of its content; however, Kite claims no responsibility for the accuracy or content of such other sites and shall not be liable for any damages or injury arising from that content. Any links to other sites are provided as merely a convenience to the viewers of this platform.
  • Kite is not affiliated with LinkedIn.com or other LinkedIn sites. Kite is not responsible for the security, privacy or other policies or practices on LinkedIn or on any of the third party websites that Kite may link to or reference through Kite’s LinkedIn page. You should carefully review the security, privacy and other policies and practices of LinkedIn and linked or referenced third-party websites.
  • Kite reserves all rights related to Kite’s LinkedIn page and may at its sole discretion add, remove or modify any content or material posted on the account, discontinue the account, accept or reject those who may wish to follow the account and respond to any questions or comments addressed to the account.
  • The Kite logo and images are trademarks of Kite and Kite owns all rights therein.
  • Any information expressed by Kite is subject to the risk factors and information no forward-looking statements contained in its filings with the Securities and Exchange Commission and available here: http://investors.gilead.com/phoenix.zhtml?c=69964&p=irol-sec.